Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the...
31 insider purchases on record · latest filing 2023-07-13.
Insiders have also filed 23 sale transactions at EVLO.